High risk — avoid this combination unless there is no good alternative.
Increased risk of major bleeding — particularly gastrointestinal bleeding (black or bloody stools, coffee-ground vomit) and bruising. Risk rises with daily/chronic NSAID use and in older adults.
Why this happens (mechanism)
Apixaban (Eliquis) inhibits clotting factor Xa, while ibuprofen and other NSAIDs impair platelet aggregation and irritate the GI lining. Stacking the two attacks blood clotting from two independent angles and adds a higher risk of mucosal injury that can bleed.
What to monitor
- Watch for black/tarry stools, coffee-ground vomit, blood in urine, or unusual bruising
- Hemoglobin/hematocrit if chronic NSAID use is unavoidable
- Stool occult blood testing if anemia develops
- Document the indication for ongoing NSAID use at every visit
Dose adjustment
No dose change to apixaban is recommended; the safer move is to use the lowest effective NSAID dose for the shortest possible duration, or switch to acetaminophen for routine pain.
Safer alternatives to consider
Does not impair platelet function or irritate the gastric lining; first-line analgesic in patients on a DOAC.
Localized application gives much lower systemic NSAID exposure for joint pain.
COX-2 selective NSAID has lower antiplatelet effect than ibuprofen, but GI/cardiovascular risk remains and concurrent use with a DOAC still raises bleeding risk.
Always discuss alternatives with your prescriber before making any change. The right choice depends on your other medications, conditions, and what is working for you today.